Natural history and treatment of renal involvement in Fabry disease.
about
Ultrastructural deposits appearing as "zebra bodies" in renal biopsy: Fabry disease?- comparative case reports.Characterization of Fabry mice treated with recombinant adeno-associated virus 2/8-mediated gene transfer.The development and use of small molecule inhibitors of glycosphingolipid metabolism for lysosomal storage diseases.A symptomatic Fabry disease mouse model generated by inducing globotriaosylceramide synthesis.Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapyIsolated microalbuminuria as the first clinical presentation of Fabry disease in an adult heterozygous femaleBroad spectrum of Fabry disease manifestation in an extended Spanish family with a new deletion in the GLA geneFoot process effacement with normal urinalysis in classic fabry disease.Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysisEffects of switching from agalsidase Beta to agalsidase alfa in 10 patients with anderson-fabry diseaseQuestioning the Pathogenic Role of the GLA p.Ala143Thr "Mutation" in Fabry Disease: Implications for Screening Studies and ERTPatients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up.Mutant alpha-galactosidase A enzymes identified in Fabry disease patients with residual enzyme activity: biochemical characterization and restoration of normal intracellular processing by 1-deoxygalactonojirimycin.Long-term outcomes with agalsidase alfa enzyme replacement therapy: Analysis using deconstructed composite events.Variable phenotypic presentations of renal involvement in Fabry disease: a case series.
P2860
Q33667541-36B7FD94-4403-4E50-A1B5-27F540E2B620Q33818578-EB42F1FD-E7F0-469B-AAFC-C09D12406F91Q33825097-AE5E2874-3579-4AE1-B22D-9C98867735E8Q34159448-176F78E6-8DE2-45DE-BF4E-4CF2569ED63DQ34945403-9C943CF6-6FF4-48E2-A0D6-03F3A3A64A73Q35573895-98FEE482-74AA-42B9-A13A-1285002D4769Q35608416-7161F3D5-AE1D-494F-8289-D70A625D3C7CQ36433223-E8032B08-C06E-41AD-AB1D-92B885CAF924Q36571559-8A9EAF21-39BC-4185-A90A-6197AE5E1B89Q36590934-DC414C79-E8F0-45C8-9BCF-2AD904517341Q36590955-9D065524-79B4-4D86-91A9-F219725409C6Q36624746-A182B583-74BE-4CE5-9871-3F79A093CF83Q42137809-DA18034A-8693-46F8-AFB9-C5BE54761A35Q47118738-9EF8AAFA-2DAD-4940-8FD7-5EBA484545F0Q54945741-1531C7D5-E039-424C-AC59-8B9D7E2CA347
P2860
Natural history and treatment of renal involvement in Fabry disease.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Natural history and treatment of renal involvement in Fabry disease.
@ast
Natural history and treatment of renal involvement in Fabry disease.
@en
Natural history and treatment of renal involvement in Fabry disease.
@nl
type
label
Natural history and treatment of renal involvement in Fabry disease.
@ast
Natural history and treatment of renal involvement in Fabry disease.
@en
Natural history and treatment of renal involvement in Fabry disease.
@nl
prefLabel
Natural history and treatment of renal involvement in Fabry disease.
@ast
Natural history and treatment of renal involvement in Fabry disease.
@en
Natural history and treatment of renal involvement in Fabry disease.
@nl
P2093
P1476
Natural history and treatment of renal involvement in Fabry disease
@en
P2093
Jeffrey B Kopp
Mary Branton
Raphael Schiffmann
P304
P478
13 Suppl 2
P577
2002-06-01T00:00:00Z